Show simple item record

dc.contributor.authorMcDonald, J. Daviden_US
dc.identifier.citationActa paediatrica (Oslo, Norway : 1992). Supplement. 1994 Dec; 407: 122-3.en_US
dc.descriptionClick on the DOI link below to access the article (may not be free).en_US
dc.description.abstractTo produce genetic-based animal models for the human disease phenylketonuria (PKU), we treated mice with the powerful germline mutagen ethylnitrosourea and screened the progeny of these animals for the symptom hyperphenylalaninemia (HPH). Six independent mutant strains have been produced to date that exhibit heritable HPH. The first mutation isolated was found to cause a reduced level of GTP-cyclohydrolase I activity and, as such, yields a model for tetrahydrobiopterin-dependent HPH. The next two mutations have yet to be fully characterized but cause syndromes that appear distinct from any PKU or HPH syndromes yet reported for humans and they are allelic. Next we isolated a mutation that caused a marked reduction in hepatic phenylalanine hydroxylase activity levels. The enzyme deficiency was not sufficient to cause a PKU syndrome but instead produced a mild HPH syndrome. This strain played an instrumental role, however, in the identification of two additional mutant strains that appear to model human PKU very accurately in the laboratory mouse. These latter strains have levels of HPH very similar to human PKU patients, exhibit a phenylalanine-dependent hypopigmentation, and have reproductive difficulties that resemble human maternal PKU.en_US
dc.relation.ispartofseriesActa paediatrica (Oslo, Norway : 1992). Supplementen_US
dc.subject.meshDisease Models, Animalen_US
dc.subject.meshMice, Transgenicen_US
dc.subject.meshPhenylalanine Hydroxylase/geneticsen_US
dc.titleThe PKU mouse project: its history, potential and implicationsen_US
dc.description.versionpeer revieweden_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record